Physician

Shaukat M Qureshi, M.D

According to 2025 Medicare claims, Shaukat Qureshi, M.D (NPI: 1821019373) practices urology in the Wilmington, DE-MD-NJ market, with the plurality of this provider's patient population coming from Salem, NJ. Qureshi uses personal NPI as billing NPI and primary practice location at 08070-2700.

Qureshi's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 147 traditional Medicare patients, billed 1,378 HCPCS/CPT codes, and received $73,809 in Medicare payments. The top billing code was 52000 (Diagnostic exam of bladder and urethra using an endoscope). Part D data shows 685 prescription claims across 152 beneficiaries totaling $422,164 in drug costs, led by Nubeqa (Darolutamide). DME data shows 11 claims. Open Payments data shows 22 records totaling $759. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a higher plateau to a lower plateau, from $165,336 to $73,809. In contrast, Part D prescription costs have moved from a lower plateau to a higher plateau, from $83,747 to $422,164. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	268	2,760	$165,336
2016	261	3,312	$164,941
2017	259	3,231	$182,097
2018	252	2,714	$154,253
2019	230	2,474	$136,830
2020	192	2,659	$105,404
2021	210	2,625	$111,148
2022	179	1,738	$91,833
2023	171	1,863	$85,185
2024	147	1,378	$73,809

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	146	634	$83,747
2016	148	624	$192,969
2017	160	710	$131,900
2018	164	734	$173,070
2019	157	733	$95,574
2020	154	674	$203,740
2021	170	698	$202,501
2022	152	601	$286,812
2023	159	697	$350,413
2024	152	685	$422,164

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	50	$577
2016	N/R	27	$334
2017	N/R	40	$544
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	11	$3,598

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
52000	Diagnostic exam of bladder and urethra using an endoscope	23	26	$204
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	77	109	$97
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	96	233	$72
36415	Insertion of needle into vein for collection of blood sample	44	77	$9
81000	Manual urinalysis test with examination using microscope, non-automated	118	316	$4

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Nubeqa	Darolutamide	11	330	$147,220
Gemtesa	Vibegron	32	1,786	$27,846
Tamsulosin Hcl	Tamsulosin Hcl	134	10,839	$2,304
Finasteride	Finasteride	49	4,020	$947
Ciprofloxacin Hcl	Ciprofloxacin Hcl	97	762	$629

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4351	Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), each	N	N/R	11	$3,598

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	22	$759	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Shaukat M. Qureshi, M.D?

Tedicare shows public-source Medicare data for Shaukat M. Qureshi, M.D (NPI 1821019373), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Shaukat M. Qureshi, M.D have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Shaukat M. Qureshi, M.D?

A separate primary affiliated billing organization is not shown for this profile in the available data.

Does Shaukat M. Qureshi, M.D have Open Payments data?

Shaukat M. Qureshi, M.D has 22 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.